View all trials
Are you a member? Sign in above to view additional information
  • Study title
    A pilot study to test the feasibility, safety and efficacy of the addition of the BiTE antibody Blinatumomab to the Interfant-06 backbone in infants with MLL-rearranged acute lymphoblastic leukemia (A collaborative study of the Interfant network)
  • Protocol ID
    BlinFant (NL59901.078.17)
  • Disease
    Disease Type Disease Subtype
    Leukaemia
    ALL
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Children's Hospital at Westmead
    • Centre Study Status:
      Open
    • Notes:
    Queensland Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
    Royal Children's Hospital Melbourne
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Pilot
  • Study type
    Treatment
  • Diagnosis stage
    New diagnosis
  • Study open date
    20/07/2018
  • Study close date
    N/A
  • Study chair
    Dr Rishi Kotecha
  • Sponsor
    Princess Maxima Center for Pediatric Oncology, Utrecht
Back to search results